Bernadette Surujbally, MSc

Senior Director/ Biostatistics
AiCuris Anti-Infective Cures AG
Bishops Stortford, England, United Kingdom

Disclosure information not submitted.

Presentation(s):

• 233 - Efficacy and safety results from the Phase 2 clinical trial of pritelivir versus foscarnet for treatment of acyclovir-refractory and/or resistant mucocutaneous HSV infections in immunocompromised subjects

  Monday, October 20, 2025
  3:51 PM - 4:03 PM US ET